CSL (OTCMKTS:CSLLY) Shares Gap Down - Should You Sell?

Key Points

• CSL Limited's share price experienced a significant drop, opening at $75.80 down from the previous close of $88.24.
• The current trading price is $74.42 with a trading volume of 4,154 shares.
• CSL Limited operates in multiple segments, including CSL Behring which focuses on plasma products, gene therapies, and recombinants.

CSL Limited Sponsored ADR (OTCMKTS:CSLLY - )'s share price gapped down before the market opened on Tuesday . The stock had previously closed at $88.24, but opened at $75.80. CSL shares last traded at $74.42, with a volume of 4,154 shares.

CSL Stock Performance

The company's 50 day simple moving average is $82.68 and its 200-day simple moving average is $80.62. The company has a current ratio of 1.86, a quick ratio of 0.85 and a debt-to-equity ratio of 0.45.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.